Literature DB >> 30932998

MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS AT THE ONSET OF EXUDATIVE CONVERSION IN AGE-RELATED MACULAR DEGENERATION.

Xiaofeng Hu1,2, Sebastian M Waldstein1, Sophie Klimscha1, Amir Sadeghipour1, Hrvoje Bogunovic1, Bianca S Gerendas1, Aaron Osborne3, Ursula Schmidt-Erfurth1.   

Abstract

PURPOSE: To characterize retinal morphology differences among different types of choroidal neovascularization and visual function changes at the onset of exudative age-related macular degeneration.
METHODS: In a post hoc analysis of a prospective clinical study, 1,097 fellow eyes from subjects with choroidal neovascularization in the study eye enrolled in the HARBOR trial were evaluated. The onset of exudation was diagnosed on monthly optical coherence tomography by two masked graders. At conversion as well as 1 month earlier, pigment epithelial detachment, intraretinal cystoid fluid, subretinal fluid, subretinal hyperreflective material, as well as ellipsoid zone and external limiting membrane loss were quantitatively analyzed. Hyperreflective foci, retinal pigment epithelial defects, haze and vitreoretinal interface status were evaluated qualitatively. Main outcome measures included visual acuity and rates of morphologic features at conversion and 1 month earlier.
RESULTS: New-onset exudation was detected in 92 eyes. One month before conversion, hyperreflective foci, pigment epithelial detachment, retinal pigment epithelial defects, and haze were present in the majority of eyes. At the onset of exudation, the volumes of intraretinal cystoid fluid, subretinal fluid, subretinal hyperreflective material and pigment epithelial detachment, and the areas of external limiting membrane and ellipsoid zone loss significantly increased. The mean vision loss was -2.2 letters. Pathognomonic patterns of the different choroidal neovascularization types were already apparent 1 month before conversion.
CONCLUSION: Characteristic choroidal neovascularization-associated morphological changes are preceding disease conversion, while vision loss at the onset of exudation is minimal. Individual lesion types are related to specific changes in optical coherence tomography morphology already before the time of conversion. Our findings may help to elucidate the pathophysiology of neovascular age-related macular degeneration and support the diagnosis of imminent disease conversion.

Entities:  

Mesh:

Year:  2020        PMID: 30932998     DOI: 10.1097/IAE.0000000000002531

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

Review 1.  Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.

Authors:  Laurent Kodjikian; Mariacristina Parravano; Andreas Clemens; Rosa Dolz-Marco; Frank G Holz; Marion R Munk; Massimo Nicolò; Federico Ricci; Rufino Silva; S James Talks; Rohini Kumar Verma; Javier Zarranz-Ventura; Sandrine A Zweifel
Journal:  Eye (Lond)       Date:  2021-04-01       Impact factor: 3.775

2.  Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration.

Authors:  Sascha Fauser; Lebriz Altay; Vasilena Sitnilska; Philip Enders; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-02       Impact factor: 3.117

Review 3.  Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications.

Authors:  Serena Fragiotta; Solmaz Abdolrahimzadeh; Rosa Dolz-Marco; Yoichi Sakurada; Orly Gal-Or; Gianluca Scuderi
Journal:  J Ophthalmol       Date:  2021-12-17       Impact factor: 1.909

4.  Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning.

Authors:  Gabriella Moraes; Dun Jack Fu; Marc Wilson; Hagar Khalid; Siegfried K Wagner; Edward Korot; Daniel Ferraz; Livia Faes; Christopher J Kelly; Terry Spitz; Praveen J Patel; Konstantinos Balaskas; Tiarnan D L Keenan; Pearse A Keane; Reena Chopra
Journal:  Ophthalmology       Date:  2020-09-24       Impact factor: 12.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.